Search results
Emcure Pharmaceuticals IPO day 2: GMP, subscription status, review to allotment date. Apply or not?...
Livemint· 22 hours agoEmcure Pharmaceuticals IPO GMP: Shares of the company are available at a premium of ₹333 in the grey...
Bansal Wire IPO: Should you subscribe to the Rs 745 cr-issue?
The Economic Times· 2 days agoThe initial public offer (IPO) of Bansal Wire has opened for subscription today. The issue, which...
Emucare Pharma sets price band of Rs 960-1008 a share for upcoming IPO
CNBC Awaaz· 7 days agoPune-based Emucare Pharmaceuticals has set a price band of Rs 960-1008 a share for its initial...
Emcure Pharmaceuticals IPO: 10 key risks investors should consider before subscribing to the...
Livemint· 2 days agoEmcure Pharmaceuticals IPO sails through first day of bidding smoothly led by non institutional and...
Replaced my Tigor XZA with a Maruti Suzuki Grand Vitara Mild Hybrid AT | Team-BHP
Team-BHP· 3 days agoMy faithful Tigor XZA 2017, was doing daily duty for my work and family travels (Review here (First...
Jimin of BTS conquers iTunes charts globally with new track 'Smeraldo Garden Marching Band' | K-pop...
The Times of India· 6 days agoOn June 28 at 1 p.m. KST, Jimin unveiled his new solo track "Smeraldo Garden Marching Band,"...
RBI’s financial stability report is not exactly worry free
Livemint· 4 days agoThough the term ‘financial stability’ encompasses much more than the stability of the banking...
Bansal Wire IPO sails through on Day 1 on robust NII, retail demand. Check GMP and other details - ...
The Economic Times· 2 days agoThe public offer is being conducted via the book-building process, with approximately 50% of the...
"I believe we have made history in the world of progressive rock.” Renaissance announce farewell US...
Louder Sound· 3 days agoHe has also been a very big help in keeping the band 'alive'! Some very talented musicians have...
Emcure Pharmaceuticals IPO booked nearly 5x so far on Day 2. Check GMP and other details
The Economic Times· 17 hours agoThe initial public offer (IPO) of Emcure Pharmaceuticals was booked nearly five times so far on...